OCUL

Ocular Therapeutix Inc
4.32
0.08 (1.89%)
Company Name Stock Ticker Symbol Market Type
Ocular Therapeutix Inc OCUL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.08 1.89% 4.32 17:14:57
Open Price Low Price High Price Close Price Prev Close
4.19 4.15 4.4804 4.32 4.24
more quote information »

Recent News

Date Time Source Heading
2/01/202306:05EDGARAmended Statement of Ownership (sc 13g/a)
1/06/202308:36EDGARCurrent Report Filing (8-k)
1/06/202308:00GLOBEOcular Therapeutix™ Provides 2022 Year End Corporate Update..
11/09/202216:49EDGARStatement of Changes in Beneficial Ownership (4)
11/08/202208:00BWOcular Therapeutix™ to Participate at Three Upcoming..
11/08/202200:35TRMNJMP Securities Sticks to Their Buy Rating for Ocular..
11/07/202216:10EDGARQuarterly Report (10-q)
11/07/202216:05EDGARCurrent Report Filing (8-k)
11/07/202216:01BWOcular Therapeutix™ Reports Third Quarter 2022 Financial..
10/26/202207:55TRMNJMP Securities Sticks to Their Buy Rating for Ocular..
10/24/202206:00BWOcular Therapeutix™ To Report Third Quarter 2022 Financial..
10/12/202216:35EDGARStatement of Changes in Beneficial Ownership (4)
10/03/202206:15TRMNH.C. Wainwright Keeps Their Buy Rating on Ocular Therapeutix..
10/03/202206:05TRMNBerenberg Bank Sticks to Its Buy Rating for Ocular..
9/30/202206:03EDGARCurrent Report Filing (8-k)
9/29/202219:52EDGARStatement of Changes in Beneficial Ownership (4)
9/28/202206:30TRMNAnalysts Offer Insights on Healthcare Companies: Ocular..
9/27/202209:20TRMNOcular Therapeutics’ (NASDAQ:OCUL) Wet AMD Interim Phase 1..
9/27/202208:45TRMNJMP Securities Reaffirms Their Buy Rating on Ocular..
9/27/202206:49DJNOcular Therapeutix Sees Positive Trial Results for OTX-TKI..
9/27/202206:00BWOcular Therapeutix™ Announces Interim 7-month Data from U.S...
9/22/202207:00BWOcular Therapeutix™ To Present Data at the American Academy..
9/07/202216:01BWOcular Therapeutix™ to Present at the H.C. Wainwright 24th..
8/17/202200:25TRMNJMP Securities Reaffirms Their Buy Rating on Ocular..
8/10/202208:00BWOcular Therapeutix™ to Present at the H.C. Wainwright 2nd..
8/09/202208:15TRMNH.C. Wainwright Remains a Buy on Ocular Therapeutix (OCUL)
8/08/202221:05TRMNJMP Securities Reaffirms Their Buy Rating on Ocular..
8/08/202216:11EDGARCurrent Report Filing (8-k)
8/08/202216:01BWOcular Therapeutix™ Reports Second Quarter 2022 Financial..
7/25/202208:00BWOcular Therapeutix™ To Report Second Quarter 2022 Financial..
7/18/202200:26TRMNJMP Securities Reaffirms Their Buy Rating on Ocular..
6/17/202208:01EDGARCurrent Report Filing (8-k)
6/08/202207:52EDGARCurrent Report Filing (8-k)
6/08/202207:00BWOcular Therapeutix™ Announces Organizational Changes to..
6/01/202208:00BWOcular Therapeutix™ to Present at the Jefferies Healthcare..
5/16/202216:58EDGARStatement of Changes in Beneficial Ownership (4)
5/16/202216:25EDGARStatement of Changes in Beneficial Ownership (4)
5/16/202203:10TRMNBerenberg Bank Thinks Ocular Therapeutix’s Stock is Going to..
5/10/202206:24TRMNAnalysts’ Top Healthcare Picks: Ocular Therapeutix (OCUL),..
5/10/202200:25TRMNAnalysts Are Bullish on Top Healthcare Stocks: Ocular..
5/09/202216:11EDGARQuarterly Report (10-q)
5/09/202216:06EDGARCurrent Report Filing (8-k)
5/09/202216:01BWOcular Therapeutix™ Reports First Quarter 2022 Financial..
5/03/202216:01BWOcular Therapeutix™ To Present Pre-Clinical Data at the..
5/02/202216:06EDGARProxy Statement (definitive) (def 14a)
4/26/202208:00BWOcular Therapeutix™ to Report First Quarter 2022 Financial..
4/25/202208:00BWOcular Therapeutix™ to Present Pre-Clinical and Clinical..
4/14/202216:35BWOcular Therapeutix™ to Present Clinical Data at the 2022..
4/12/202222:46PRNUSAffaMed Therapeutics Announces New Drug Approval for..
3/04/202208:00BWOcular Therapeutix™ to Present at the Cowen 42nd Annual..